Ayush Sector Enters New Phase as Insurance Coverage and Hospitals Expand

India's traditional medicine sector is increasingly moving beyond education and primary care toward hospital-based and insured healthcare services.

A new report says Ayurveda and other Ayush systems are entering a new phase of expansion as insurance coverage, hospitals and private investment increase, while evidence-based treatment remains a key requirement.

Reported by: System Admin
•
October 7, 2026
•
5 min read
Dr. Arvind Deshmukh

MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH

Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute

Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Ayush Sector Enters New Phase as Insurance Coverage and Hospitals Expand
Photo: Clinical Archives / HealthGhuru EditorialVerified Creative Rights

India's Ayush sector is undergoing a significant change as traditional medicine systems increasingly move beyond educational institutions and primary healthcare into hospital-based and specialized services.

Recent reporting indicates that wider insurance coverage and increasing private investment are helping drive this expansion. The number of undergraduate Ayush colleges in India has also increased substantially over the past decade.

For Ayurveda specifically, the development could improve access to treatment for people who choose traditional healthcare approaches. However, the growing integration of Ayurveda into mainstream healthcare also increases the importance of clinical evidence, safety monitoring and professional standards.

The distinction between traditional medical practice and unsupported health claims is particularly important as Ayurveda becomes more visible through social media and commercial wellness platforms.

India's government has also emphasized evidence-led research and the integration of traditional systems with modern healthcare. The long-term success of this approach will depend on ensuring that treatments are appropriately evaluated for effectiveness, safety and interactions with conventional medicines.

Story Photo Gallery

Photo 1
Dr. Arvind Deshmukh

Dr. Arvind Deshmukh

VERIFIED

Cardiologist & Electrophysiologist

Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.

Scientific References & Journal Citations

  1. National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
  2. Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
  3. European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.

Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.